Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMJ Case Rep ; 17(4)2024 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-38575335

RESUMEN

A term neonate presented with cyanosis from birth, with refractory hypoxaemia despite intubation, administration of 100% oxygen and inhaled nitric oxide. Structural congenital heart disease was excluded. He developed profuse pulmonary haemorrhage at 6 hours of life with worsening hypoxia and was transferred to a paediatric intensive care unit (PICU) for initiation of veno-venous extracorporeal membrane oxygenation (vvECMO). Endotracheal aspirates from both the birth hospital and the PICU were positive for Bacillus cereus, with all other investigations finding no alternative cause for his presentation. Of note, mother was a practising veterinarian raising another potential source of exposure to this pathogen. A full recovery occurred after a total of 5 days of vvECMO, 13 days of ventilation and 20 days of PICU stay.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Neumonía , Masculino , Recién Nacido , Humanos , Niño , Bacillus cereus , Pulmón , Óxido Nítrico , Oxígeno
2.
BMJ Case Rep ; 16(11)2023 Nov 23.
Artículo en Inglés | MEDLINE | ID: mdl-37996148

RESUMEN

A previously fit and well girl of middle-childhood age presented to her local emergency department after waking with upper-facial swelling. She had a 24-hour preceding history of mild vomiting illness and fatigue. Examination revealed palpable splenomegaly and mild cervical lymphadenopathy, with pitting oedema of the forehead, nasal bridge and eyelids. Admission full blood count showed anaemia and neutropenia, and further investigations confirmed a diagnosis of acute lymphoblastic B-cell leukaemia. X-ray of the chest and CT imaging did not reveal any local facial mass, veno-occlusive disease or mediastinal pathology to explain her facial swelling. She was referred to the tertiary paediatric oncology service for commencement of induction chemotherapy.


Asunto(s)
Angioedema , Leucemia-Linfoma Linfoblástico de Células Precursoras B , Leucemia-Linfoma Linfoblástico de Células Precursoras , Femenino , Humanos , Niño , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Radiografía , Diagnóstico Diferencial , Edema/etiología
3.
Percept Mot Skills ; 125(4): 817-833, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29886806

RESUMEN

Set shot goal-kicking is recognized as an important skill in Australian Football (AF), accounting for over half of all goals kicked in the Australian Football League (AFL). However, as knowledge surrounding its performance is limited, this study described the frequency, types, and outcomes of set shots in the AFL and investigated the impact of task, personal, and environmental constraints on goal-kicking performance. We analyzed video footage of set shots from all 198 matches of the 2012 season, collecting data for kick distance, kick angle, player position, player experience (i.e., general and specific), kick outcome, and weather status. We found an average of 23.0 (standard deviation [ SD] = 4.5) set shots/match, with a mean accuracy of 55.0% ( SD = 0.7%). Kicking accuracy decreased with incremental increases in kick distance, with accuracy ranging from 97% (0-15 m) to 36% (≥50 m). Key forwards were more accurate kickers than other players. There was no significant effect of player experience. The number of set shots taken decreased by 13% in wet weather conditions. The primary determinant of elite set shot goal-kicking performance was the interaction of kick distance and angle (task difficulty). This research adds to an understanding of how personal, environmental, and match constraints influence this closed skill performance in AF match play.


Asunto(s)
Rendimiento Atlético/fisiología , Fútbol Americano/fisiología , Desempeño Psicomotor/fisiología , Aptitud , Australia , Humanos , Masculino
4.
J Agric Food Chem ; 66(26): 6480-6486, 2018 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-28812885

RESUMEN

Plant protection products containing nanomaterials that alter the functionality or risk profile of active ingredients (nano-enabled pesticides) promise many benefits over conventional pesticide products. These benefits may include improved formulation characteristics, easier application, better targeting of pest species, increased efficacy, lower application rates, and enhanced environmental safety. After many years of research and development, nano-enabled pesticides are starting to make their way into the market. The introduction of this technology raises a number of issues for regulators, including how does the ecological risk assessment of nano-enabled pesticide products differ from that of conventional plant protection products? In this paper, a group drawn from regulatory agencies, academia, research, and the agrochemicals industry offers a perspective on relevant considerations pertaining to the problem formulation phase of the ecological risk assessment of nano-enabled pesticides.


Asunto(s)
Nanoestructuras/química , Plaguicidas/química , Composición de Medicamentos , Nanoestructuras/toxicidad , Plaguicidas/toxicidad , Medición de Riesgo
5.
Am J Manag Care ; 18(6): e234-7, 2012 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-22775075

RESUMEN

OBJECTIVES: To identify barriers encountered by case managers in hospitals, home care agencies, and nursing homes in the transition of the obese patient from the hospital to the community. STUDY DESIGN: Exploratory descriptive design was used. Hospital case managers, nursing home administrators, and Medicare-certified home healthcare agency administrators were surveyed to identify barriers. METHODS: Hospital case managers in each licensed acute care hospital, directors of licensed nursing homes, and administrators of the Medicarecertified home healthcare agencies in 1 southern state were surveyed. The survey instrument was designed by the investigators based on variables identified in the literature or encountered within their practice. Instruments consisted of items related to the respondent's experience with barriers such as patient size, degree of patient independence, patient care requirements, staffing levels, and the need for assistive equipment, as well as items used to collect basic demographic information. RESULTS: Both hospital case managers and nursing home directors reported as major barriers the equipment, the size of the patient, patient independence, and finances. Home care agency directors reported that the presence or absence of a competent caregiver was the major factor in the decision to accept or not accept an obese patient. CONCLUSIONS: Transition of the obese patient presents major challenges. Further exploration is needed to identify the extent of problems and make policy recommendations toward a solution.


Asunto(s)
Accesibilidad a los Servicios de Salud , Necesidades y Demandas de Servicios de Salud , Hospitales , Obesidad/complicaciones , Características de la Residencia , Continuidad de la Atención al Paciente , Encuestas de Atención de la Salud , Humanos , Obesidad/psicología , Alta del Paciente , Investigación Cualitativa , Factores de Tiempo
6.
Methods Mol Biol ; 726: 379-91, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21424462

RESUMEN

Scientists constantly generate great ideas in the laboratory and, as most of us were meant to believe, we should publish or perish. After all, what use is a great scientific idea if it is not shared with the rest of the scientific community? What some scientists forget is that a good idea can be worth something - sometimes it can be worth a lot (of money)! What do you do if you believe that your idea has some commercial potential? How do you turn this idea into a business? This chapter gives the aspiring scientific entrepreneur some (hopefully) valuable advice on topics like choosing the right people for your management team, determining inventorship of the technology and ownership shares in the new company, protecting your intellectual property, and others; finally, it describes some of the various pitfalls you may encounter when commercializing an early stage technology and instructions on how to avoid them.


Asunto(s)
Disciplinas de las Ciencias Biológicas/organización & administración , Emprendimiento , Industrias/organización & administración , Disciplinas de las Ciencias Biológicas/economía , Disciplinas de las Ciencias Biológicas/tendencias , Emprendimiento/economía , Emprendimiento/organización & administración , Humanos , Industrias/economía , Industrias/tendencias , Recursos Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...